Umoove

Face and Eye Tracking Technology

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in August 2012 by Tuvia Elbaum, Yitzi Kempinski, and Nir Blushtein, Umoove operates with 1–10 employees. The company has raised $2.75 million across four funding rounds, with Bouaziz & Partners and Flint Capital among its investors. Umoove has developed advanced face and eye tracking software that functions on mobile devices without requiring additional hardware.

Business overview

Umoove develops face and eye tracking software designed for integration into any mobile device, eliminating the need for supplementary hardware. Its core technology enables devices to interpret face and eye movements, transforming them into interactive language and valuable data. This technology serves various markets, including gaming, advertising, sports, and wearable AR/VR, with a particular focus on healthcare for analyzing brain activity to observe conditions such as ADHD, concussions, strokes, autism, and Parkinson’s disease. Umoove operates within the Digital Health and Medical Technologies sector, leveraging artificial intelligence, computer vision, and augmented/virtual reality.

Strategic signal

In September 2019, Umoove was highlighted for bringing advanced reality experiences through its innovative face and eye-tracking technology. This signals the company's continued relevance and potential for growth in the augmented and virtual reality markets, demonstrating its ability to adapt its core technology for diverse applications beyond healthcare, which is a positive indicator for investors looking for versatile technology platforms.

Company Intelligence Q&A

What is Umoove's primary technology?
Umoove's primary technology is face and eye tracking software designed to operate on any mobile device without requiring additional hardware. It uses the front-facing camera to track movements and interpret them into interactive data.
When was Umoove founded and by whom?
Umoove was founded in August 2012 by Tuvia Elbaum, Yitzi Kempinski, and Nir Blushtein.
What is the total capital raised by Umoove?
Umoove has raised a total of $2.75 million across four funding rounds.
Which investors participated in Umoove's April 2014 funding round?
In April 2014, Umoove received funding from Bouaziz & Partners and Flint Capital.
How does Umoove's technology apply to the healthcare sector?
Umoove's technology provides a window into analyzing brain activity by tracking eye movements, which can assist in observing conditions such as ADHD, concussions, strokes, autism, and Parkinson’s disease.